{"id":"https://openalex.org/W2496801530","doi":"https://doi.org/10.1007/s40265-016-0613-0","title":"Unmet Needs in LDL-C Lowering: When Statins Won\u2019t Do!","display_name":"Unmet Needs in LDL-C Lowering: When Statins Won\u2019t Do!","alternate_titles":[],"publication_year":2016,"publication_date":"2016-07-25","ids":{"openalex":"https://openalex.org/W2496801530","doi":"https://doi.org/10.1007/s40265-016-0613-0","mag":"2496801530","pmid":"https://pubmed.ncbi.nlm.nih.gov/27456066","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4974266"},"language":"en","primary_location":{"id":"doi:10.1007/s40265-016-0613-0","doi":"https://doi.org/10.1007/s40265-016-0613-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40265-016-0613-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40265-016-0613-0.pdf","source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2496801530"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40265-016-0613-0.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087882435","display_name":"Stephan Kr\u00e4henb\u00fchl","orcid":"https://orcid.org/0000-0001-8347-4145","observed_orcids":["https://orcid.org/0000-0001-8347-4145"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Stephan Kr\u00e4henb\u00fchl","raw_affiliation_strings":["Department of Clinical Research, University of Basel, Basel, Switzerland. stephan.kraehenbuehl@usb.ch","Division of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland. stephan.kraehenbuehl@usb.ch","Division of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research, University of Basel, Basel, Switzerland. stephan.kraehenbuehl@usb.ch","institution_ids":["https://openalex.org/I1850255"]},{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland. stephan.kraehenbuehl@usb.ch","institution_ids":["https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028167145","display_name":"Ivana Pavik-Mezzour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139000","display_name":"Amgen (Switzerland)","ror":"https://ror.org/045wjte67","country_code":"CH","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210139000"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ivana Pavik-Mezzour","raw_affiliation_strings":["Amgen Switzerland AG, Dammstrasse 21, 6301, Zug, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Switzerland AG, Dammstrasse 21, 6301, Zug, Switzerland","institution_ids":["https://openalex.org/I4210139000"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027046285","display_name":"Arnold von Eckardstein","orcid":"https://orcid.org/0000-0002-1666-2266","observed_orcids":["https://orcid.org/0000-0002-1666-2266"]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arnold von Eckardstein","raw_affiliation_strings":["Institute of Clinical Chemistry, University Hospital Z\u00fcrich, Zurich, Switzerland","Z\u00fcrich Center for Integrative Human Physiology, University of Z\u00fcrich, Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Clinical Chemistry, University Hospital Z\u00fcrich, Zurich, Switzerland","institution_ids":["https://openalex.org/I4210100468"]},{"raw_affiliation_string":"Z\u00fcrich Center for Integrative Human Physiology, University of Z\u00fcrich, Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5087882435"],"corresponding_institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"],"apc_list":{"value":5990,"currency":"USD","value_usd":5990},"apc_paid":{"value":5990,"currency":"USD","value_usd":5990},"fwci":1.1106,"has_fulltext":true,"cited_by_count":100,"citation_normalized_percentile":{"value":0.75074937,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"76","issue":"12","first_page":"1175","last_page":"1190"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.9290000200271606},{"id":"https://openalex.org/keywords/statin-therapy","display_name":"statin therapy","score":0.7310000061988831},{"id":"https://openalex.org/keywords/statin-adverse-effects","display_name":"statin adverse effects","score":0.8220000267028809},{"id":"https://openalex.org/keywords/statin-induced-myopathy","display_name":"statin-induced myopathy","score":0.6819999814033508},{"id":"https://openalex.org/keywords/familial-hypercholesterolemia","display_name":"familial hypercholesterolemia","score":0.9039999842643738},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9879999756813049},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/evolocumab","display_name":"evolocumab","score":0.9190000295639038},{"id":"https://openalex.org/keywords/alirocumab","display_name":"alirocumab","score":1.0},{"id":"https://openalex.org/keywords/cetp-inhibitors","display_name":"CETP inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5699999928474426},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.699999988079071},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.9522992968559265},{"id":"https://openalex.org/C2780902209","wikidata":"https://www.wikidata.org/wiki/Q4726914","display_name":"Alirocumab","level":5,"score":0.9260841608047485},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9228768944740295},{"id":"https://openalex.org/C2778114629","wikidata":"https://www.wikidata.org/wiki/Q15623825","display_name":"Evolocumab","level":5,"score":0.8590447902679443},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6876678466796875},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.5979344248771667},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.5169129371643066},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4729437828063965},{"id":"https://openalex.org/C2778824825","wikidata":"https://www.wikidata.org/wiki/Q7250439","display_name":"Proprotein convertase","level":5,"score":0.4709304869174957},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4514521360397339},{"id":"https://openalex.org/C2778849439","wikidata":"https://www.wikidata.org/wiki/Q6397985","display_name":"Kexin","level":5,"score":0.4127236306667328},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3878171443939209},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.30272090435028076},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.2176510989665985},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.11352765560150146},{"id":"https://openalex.org/C2780745583","wikidata":"https://www.wikidata.org/wiki/Q1316030","display_name":"Apolipoprotein A1","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000069438","descriptor_name":"Ezetimibe","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069438","descriptor_name":"Ezetimibe","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020860","descriptor_name":"Subtilisin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020860","descriptor_name":"Subtilisin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1007/s40265-016-0613-0","doi":"https://doi.org/10.1007/s40265-016-0613-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40265-016-0613-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40265-016-0613-0.pdf","source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4974266","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4974266","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4974266/pdf/40265_2016_Article_613.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"Text"},{"id":"pmid:27456066","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27456066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"Journal Article"},{"id":"pmh:oai:edoc.unibas.ch:62287","doi":null,"is_oa":false,"landing_page_url":"https://edoc.unibas.ch/62287/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401836","display_name":"edoc (University of Basel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1850255","host_organization_name":"University of Basel","host_organization_lineage":["https://openalex.org/I1850255"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/123872","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/123872","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Kr\u00e4henb\u00fchl, S., Pavik-Mezzour, I., & von Eckardstein, A. (2016). Unmet needs in LDL-C lowering: when statins won\u2019t do! Drugs, 76, 1175\u20131190. https://doi.org/10.1007/s40265-016-0613-0","raw_type":"Journal Article"},{"id":"doi:10.5167/uzh-129305","doi":"https://doi.org/10.5167/uzh-129305","is_oa":true,"landing_page_url":"https://doi.org/10.5167/uzh-129305","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1007/s40265-016-0613-0","doi":"https://doi.org/10.1007/s40265-016-0613-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40265-016-0613-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40265-016-0613-0.pdf","source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2496801530.pdf","grobid_xml":"https://content.openalex.org/works/W2496801530.grobid-xml"},"referenced_works_count":122,"referenced_works":["https://openalex.org/W54812721","https://openalex.org/W120848922","https://openalex.org/W121888607","https://openalex.org/W185387885","https://openalex.org/W197402492","https://openalex.org/W867395513","https://openalex.org/W1511974464","https://openalex.org/W1520609538","https://openalex.org/W1574102128","https://openalex.org/W1604547439","https://openalex.org/W1618479134","https://openalex.org/W1816597323","https://openalex.org/W1883027722","https://openalex.org/W1962272706","https://openalex.org/W1963958736","https://openalex.org/W1964240590","https://openalex.org/W1964590451","https://openalex.org/W1967021869","https://openalex.org/W1968837758","https://openalex.org/W1968949098","https://openalex.org/W1970049038","https://openalex.org/W1972661406","https://openalex.org/W1974005985","https://openalex.org/W1980786839","https://openalex.org/W1981624214","https://openalex.org/W1982914740","https://openalex.org/W1983793369","https://openalex.org/W1985747185","https://openalex.org/W1988748406","https://openalex.org/W1989343587","https://openalex.org/W1990993346","https://openalex.org/W1995085584","https://openalex.org/W1998569580","https://openalex.org/W2001314633","https://openalex.org/W2001328643","https://openalex.org/W2001774934","https://openalex.org/W2009383197","https://openalex.org/W2010033213","https://openalex.org/W2011221956","https://openalex.org/W2014561045","https://openalex.org/W2016195709","https://openalex.org/W2018719851","https://openalex.org/W2019676124","https://openalex.org/W2021042232","https://openalex.org/W2023735564","https://openalex.org/W2024930123","https://openalex.org/W2025860084","https://openalex.org/W2026776049","https://openalex.org/W2029471511","https://openalex.org/W2042222636","https://openalex.org/W2042833179","https://openalex.org/W2044857086","https://openalex.org/W2051461685","https://openalex.org/W2051922899","https://openalex.org/W2054489926","https://openalex.org/W2054559068","https://openalex.org/W2056411372","https://openalex.org/W2058647728","https://openalex.org/W2059078444","https://openalex.org/W2060450840","https://openalex.org/W2064994526","https://openalex.org/W2067539811","https://openalex.org/W2069510074","https://openalex.org/W2069616685","https://openalex.org/W2071891597","https://openalex.org/W2082732641","https://openalex.org/W2086524674","https://openalex.org/W2090464684","https://openalex.org/W2091144312","https://openalex.org/W2091769487","https://openalex.org/W2097319856","https://openalex.org/W2097648921","https://openalex.org/W2100796591","https://openalex.org/W2100933656","https://openalex.org/W2101185950","https://openalex.org/W2101860651","https://openalex.org/W2102238081","https://openalex.org/W2104290329","https://openalex.org/W2107165713","https://openalex.org/W2116108398","https://openalex.org/W2116205322","https://openalex.org/W2118184073","https://openalex.org/W2128572248","https://openalex.org/W2129809363","https://openalex.org/W2130117548","https://openalex.org/W2131607570","https://openalex.org/W2133043280","https://openalex.org/W2134159541","https://openalex.org/W2141210634","https://openalex.org/W2141676927","https://openalex.org/W2141898196","https://openalex.org/W2142526970","https://openalex.org/W2142627469","https://openalex.org/W2143741651","https://openalex.org/W2144577176","https://openalex.org/W2148041292","https://openalex.org/W2148092884","https://openalex.org/W2149027941","https://openalex.org/W2156017502","https://openalex.org/W2159243445","https://openalex.org/W2164089346","https://openalex.org/W2165605025","https://openalex.org/W2165624352","https://openalex.org/W2165791625","https://openalex.org/W2166934777","https://openalex.org/W2168536722","https://openalex.org/W2170525407","https://openalex.org/W2171736612","https://openalex.org/W2200285648","https://openalex.org/W2210694332","https://openalex.org/W2218353190","https://openalex.org/W2266600614","https://openalex.org/W2314193179","https://openalex.org/W2477477042","https://openalex.org/W2521539105","https://openalex.org/W2908289332","https://openalex.org/W3001764054","https://openalex.org/W3026814848","https://openalex.org/W3154897655","https://openalex.org/W3205881446","https://openalex.org/W3209992856","https://openalex.org/W6607828777"],"related_works":["https://openalex.org/W4414984365","https://openalex.org/W4408166236","https://openalex.org/W7162505714","https://openalex.org/W4400000010","https://openalex.org/W2756029751","https://openalex.org/W2014979854","https://openalex.org/W2021321594","https://openalex.org/W4385483400","https://openalex.org/W7154944195","https://openalex.org/W1725677343"],"abstract_inverted_index":{"The":[0],"use":[1],"of":[2,14,26,34,66,90,110,141,181,190],"low-density":[3],"lipoprotein":[4],"cholesterol":[5],"(LDL-C)-lowering":[6],"medications":[7],"has":[8,38],"led":[9],"to":[10,41,80,186],"a":[11,170],"significant":[12],"reduction":[13],"cardiovascular":[15,35],"risk":[16,52],"in":[17,44,49,96,103],"both":[18],"primary":[19],"and":[20,32,48,55,153],"secondary":[21],"prevention.":[22],"Statin":[23],"therapy,":[24,143],"one":[25],"the":[27,30,51,67,83,88,188],"cornerstones":[28],"for":[29,53,122],"prevention":[31],"treatment":[33,135,182],"disease":[36],"(CVD),":[37],"been":[39],"demonstrated":[40],"be":[42],"effective":[43],"lowering":[45],"LDL-C":[46,92,111,125],"levels":[47,93,109],"reducing":[50,124],"CVD":[54,99],"is":[56,70,94,120],"generally":[57],"well-tolerated.":[58],"However,":[59],"compliance":[60],"with":[61,82,98,105,114,167],"statins":[62],"remains":[63],"suboptimal.":[64],"One":[65],"main":[68],"reasons":[69],"limitations":[71],"by":[72],"adverse":[73],"events,":[74],"notably":[75],"myopathies,":[76],"which":[77,176],"can":[78],"lead":[79],"non-compliance":[81],"prescribed":[84],"statin":[85,118,142],"regimen.":[86],"Reducing":[87],"burden":[89],"elevated":[91],"critical":[95],"patients":[97,104,113,161,191],"as":[100,102,117],"well":[101],"very":[106],"high":[107],"baseline":[108],"(e.g.":[112],"familial":[115],"hypercholesterolaemia),":[116],"therapy":[119,166],"insufficient":[121],"optimally":[123],"below":[126],"target":[127],"values.":[128],"In":[129],"this":[130],"review,":[131],"we":[132],"discuss":[133],"alternative":[134],"options":[136],"after":[137],"maximally":[138],"tolerated":[139],"doses":[140],"including":[144],"ezetimibe,":[145],"proprotein":[146],"convertase":[147],"subtilisin/kexin":[148],"type":[149],"9":[150],"(PCSK9)":[151],"inhibitors,":[152],"cholesteryl":[154],"ester":[155],"transfer":[156],"protein":[157],"(CETP)":[158],"inhibitors.":[159],"Difficult-to-treat":[160],"may":[162],"benefit":[163,195],"from":[164,196],"combination":[165],"ezetimibe":[168],"or":[169,174],"PCSK9":[171],"inhibitor":[172],"(evolocumab":[173],"alirocumab,":[175],"are":[177,184],"now":[178],"available).":[179],"Updates":[180],"guidelines":[183],"needed":[185],"guide":[187],"management":[189],"who":[192],"will":[193],"best":[194],"these":[197],"new":[198],"treatments.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2496801530","counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-08-23T00:00:00"}
